We are live on ! Find out more
PYXS icon

Pyxis Oncology
PYXS

72 hedge funds and large institutions have $97.8M invested in Pyxis Oncology in 2024 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 22 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

517% more capital invested

Capital invested by funds: $15.8M → $97.8M (+$81.9M)

340% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 5

244% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 9

167% more call options, than puts

Call options by funds: $543K | Put options by funds: $203K

41% more funds holding

Funds holding: 51 → 72 (+21)

19.63% more ownership

Funds ownership: 19.85% → 39.48% (+20%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
72
Holders Change
+21
Holders Change %
+41.18%
% of All Funds
1.04%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
31
Increased
22
Reduced
5
Closed
9
Calls
$543K
Puts
$203K
Net Calls
+$340K
Net Calls Change
+$318K

Top Buyers

1
DTC
Deep Track Capital
Connecticut
+$17.6M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$10.9M
3
SC
Stempoint Capital
New York
+$7.55M
4
IC
Ikarian Capital
Texas
+$6.99M
5
LCM
Laurion Capital Management
New York
+$2.9M

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$909K
2
VPC
Vestal Point Capital
New York
-$792K
3
Citadel Advisors
Citadel Advisors
Florida
-$432K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$204K
5
HIS
Harvest Investment Services
Illinois
-$201K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$466K +$111K +26,300 +32%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$434K – – –
ECM
28
ExodusPoint Capital Management
New York
$381K +$376K +89,471 New
SFI
29
Susquehanna Fundamental Investments
Pennsylvania
$351K +$347K +82,447 New
CIC
30
Cornercap Investment Counsel
Georgia
$319K – – –
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$296K +$242K +57,628 +487%
YF
32
Yu Fan
$295K – – –
Squarepoint
33
Squarepoint
New York
$291K +$287K +68,358 New
XT
34
XTX Topco
Cayman Islands
$281K +$191K +45,303 +220%
CCC
35
Cable Car Capital
California
$262K – – –
Northern Trust
36
Northern Trust
Illinois
$261K +$4K +951 +2%
MTIM
37
Marathon Trading Investment Management
Pennsylvania
$243K +$240K +57,000 New
P8IP
38
Pier 88 Investment Partners
California
$219K +$216K +51,360 New
UOC
39
University of Chicago
Illinois
$208K – – –
Citigroup
40
Citigroup
New York
$190K +$188K +44,695 New
Morgan Stanley
41
Morgan Stanley
New York
$185K +$156K +37,127 +580%
JF
42
Jump Financial
Illinois
$172K +$170K +40,452 New
American Century Companies
43
American Century Companies
Missouri
$159K +$99.2K +23,580 +171%
BHCM
44
Brevan Howard Capital Management
Jersey
$153K +$151K +35,987 New
Commonwealth Equity Services
45
Commonwealth Equity Services
Massachusetts
$129K +$72.8K +17,300 +134%
PAS
46
Point72 Asia (Singapore)
Singapore
$127K +$125K +29,835 New
Bank of America
47
Bank of America
North Carolina
$127K +$41.5K +9,869 +50%
Cetera Investment Advisers
48
Cetera Investment Advisers
Illinois
$125K +$37.8K +8,998 +44%
UBS Group
49
UBS Group
Switzerland
$120K +$106K +25,295 +856%
YIH
50
Y-Intercept (HK)
Hong Kong
$120K +$118K +28,053 New
1
2
3 4

PYXS Hedge Fund Activity: Q1 2024 in Review

72 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Pyxis Oncology (PYXS) for Q1 2024, worth a combined $97.8M — up 517% from $15.8M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new PYXS positions and 9 closed out — a net gain of 22 holders — while 22 added to existing stakes and 5 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $17.6M. The largest seller was Renaissance Technologies, cutting an estimated $909K.

  • 72 institutional investors held Pyxis Oncology (PYXS) as of Q1 2024, up from 51 in Q4 2023.
  • Funds reported $97.8M of Pyxis Oncology stock for Q1 2024, up 517% quarter-over-quarter.
  • 31 funds opened new Pyxis Oncology positions in Q1 2024 and 9 closed out, a net change of +22 holders.
  • The largest Pyxis Oncology buyer in Q1 2024 was Deep Track Capital, an estimated $17.6M added.
  • The largest Pyxis Oncology seller in Q1 2024 was Renaissance Technologies, an estimated $909K sold.

Based on aggregated 13F filings for Q1 2024.